Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.65 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.59 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.52 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391827 | 1.00 | ALDH1A1 (0.65) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL30186719 | 1.00 | ALDH1A1 (0.65) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL9644939 | 0.89 | HPRT1 (0.70) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL4181934 | 0.85 | ALDH1A1 (0.58) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL10860356 | 0.82 | AKR1B1 (0.45) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL11417516 | 0.82 | ALDH1A1 (0.52) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL9643984 | 0.82 | CYP2A6 (0.55) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL5332442 | 0.82 | TDP1 (0.55) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL9214539 | 0.82 | CYP2A6 (0.52) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 | |
| SCHEMBL9765524 | 0.82 | KDM4E (0.55) | ALDH1A1HSD17B10CYP2A6TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1673 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132314-A1 | ADHESIVE TAPE | ETERNAL MATERIALS CO., LTD. (TW) | 2026-05-14 | — | — | US | claimed |
| EP-4734894-A2 | POLYMER COMPOSITIONS AND USES THEREOF | The University of Melbourne (AU) | 2026-05-06 | — | — | EP | claimed |
| WO-2025006821-A9 | POLYMER COMPOSITIONS AND USES THEREOF | THE UNIVERSITY OF MELBOURNE (AU) | 2026-04-30 | — | — | WO | claimed |
| EP-4574181-A2 | BIOADHESIVE FOR CORNEAL REPAIR | The Brigham and Women's Hospital Inc. (US) | 2025-06-25 | — | — | EP | claimed |
| WO-2025106936-A1 | POLY(METH)ACRYLIMIDE MATERIALS WITH ENHANCED THERMOMECHANICAL PROPERTIES | GENCORES, INC. (US) | 2025-05-22 | — | — | WO | claimed |
| EP-3413940-B1 | BIOADHESIVE FOR CORNEAL REPAIR | BRIGHAM & WOMENS HOSPITAL INC (US) | 2025-05-07 | — | — | EP | claimed |
| WO-2025014975-A2 | LUBRICIOUS COATINGS FOR SKIS AND SNOWBOARDS AND RELATED SYSTEMS AND METHODS OF USE | Drake Holdings, Inc. (US) | 2025-01-16 | — | — | WO | claimed |
| WO-2025005739-A1 | BARRIER MEMBRANE FOR BONE REGENERATION TO MAINTAIN MICROORGANISM-CELL SYMBIOSIS AND METHOD FOR PRODUCING SAME | 연세대학교 산학협력단 | 2025-01-02 | — | — | WO | claimed |
| WO-2025006821-A2 | POLYMER COMPOSITIONS AND USES THEREOF | THE UNIVERSITY OF MELBOURNE (AU) | 2025-01-02 | — | — | WO | claimed |
| US-20240269347-A1 | BIOADHESIVE FOR CORNEAL REPAIR | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. | 2024-08-15 | — | — | US | claimed |
| EP-0799201-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED 4-ETHYL-PIPERIDINES | NEUROSEARCH AS (DK) | 2001-09-26 | — | — | EP | claimed |
| WO-2000075121-A2 | PROCESS FOR PREPARING 10,11-METHANOBENZOSUBERANE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-12-14 | — | — | WO | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0639547-B1 | Composition for the production of smoke opaque to infrared radiation | BUCK CHEM TECH WERKE (DE) | 1996-10-30 | — | — | EP | claimed |
| US-5389308-A | Compact with specified density comprising magnesium powder, fluorinated organic polymer, chloroparaffin, specified aromatic compound as aerosol supplier | BUCK WERKE GMBH & CO. (DE) | 1995-02-14 | — | — | US | claimed |
| WO-1994005276-A1 | CYTOTOXIC COMPOUNDS | MORGAN LEE R (US) | 1994-03-17 | — | — | WO | claimed |
| EP-0272621-B1 | Method for the production of 5H-dibenzo[a,d]cyclohepten-5-ones | BASF Aktiengesellschaft (DE) | 1991-11-27 | — | — | EP | claimed |
| EP-0035903-B1 | DIBENZOCYCLOHEPTENYLIDENES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1984-10-17 | — | — | EP | claimed |
| EP-0089759-A1 | Dibenzocycloheptenylidene compounds for use in modulating the immune response | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-09-28 | — | — | EP | claimed |
| EP-0035903-A1 | Dibenzocycloheptenylidenes and their use in pharmaceutical compositions | AMERICAN HOME PRODUCTS CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132314-A1 | ADHESIVE TAPE | GGH, ALKBH3, OGDH | ALDH1A1 135/4885HSD17B10 815/4885CYP2A6 793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.